FindTrial
Sign In

Study on treatment strategy of COVID-19 by Radiologic imaging combined with pathology diagnosis with AI

Study on treatment strategy of COVID-19 by Radiologic imaging combined with pathology diagnosis with AI

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100047688
Enrollment
Unknown
Registered
2021-06-21
Start date
2021-08-01
Completion date
Unknown
Last updated
2022-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

case group:Nil

Sponsors

Southwest Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
53 Years to 89 Years

Inclusion criteria

Inclusion criteria: 1.Clinically diagnosed as COVID-19 died patients.

Exclusion criteria

Exclusion criteria: Nil

Design outcomes

Primary

MeasureTime frame
Image CT data;Pathological HE data;—

Countries

China

Contacts

Public ContactBian Xiuwu

Southwest Hospital of Army Medical University

bianxiuwuoffice@163.com+86 13708373857

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026